Abbvie - COVID-19 and the Management of Patients with Rheumatic Musculoskeletal Diseases


Industry room 1
English
Satellite Symposia
03 June 2021 08:15 - 09:45

Learning Objective(s): 
  • Registry update on COVID-19 in patients with RMD  
  • Treatment options for the management of COVID-19 in patients with RMD 
  • Vaccinations and COVID-19 in RMD 
  • Practical considerations on how to manage patients in a COVID-19 environment.
  • This Symposium aims to review the impact of COVID-19. Our faculty will discuss the current data available and the influence of COVID-19 on the management of patients with rheumatic diseases and discuss the impact and development of vaccines. 

Presentations

Title Time Calendar .ics
Welcome, introduction and Learning Objectives
03 June 2021 08:15 - 08:25 .ics
COVID-19 Global Registries: What have we learned?
03 June 2021 08:25 - 08:45 .ics
Treatment Guidance for patients with RMD in the COVID-19 Era
03 June 2021 08:45 - 09:05 .ics
COVID-19 vaccination for patients with RMD: Experience from the UK
03 June 2021 09:05 - 09:25 .ics
Discussion: Telemedicine and communication: What will be the ‘new normal’
03 June 2021 09:25 - 09:45 .ics
Summary and Close
03 June 2021 09:45 - 09:45 .ics